J. V. Hoof

Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.

H. Schuitemaker, N. Frahm, M. McElrath, 2016, JAMA.

Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques

D. Lauffenburger, H. Schuitemaker, R. Baric, 2020, Nature.

Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting

Mathieu Le Gars, H. Schuitemaker, D. Heerwegh, 2021, medRxiv.

Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial

Mathieu Le Gars, H. Schuitemaker, P. van Damme, 2020, medRxiv.